908 Devices Inc. (NASDAQ:MASS)
| Market Cap | 456.63M+22.6% |
| Revenue (ttm) | 60.84M+4.6% |
| Net Income | -34.48M-87.0% |
| EPS | -0.95-143.6% |
| Shares Out | 41.03M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 48,087 |
| Open | 11.66 |
| Previous Close | 11.78 |
| Day's Range | 11.13 - 11.69 |
| 52-Week Range | 5.03 - 13.35 |
| Beta | 0.63 |
| Analysts | Buy |
| Price Target | 12.00(+7.82%) |
| Earnings Date | Nov 9, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About MASS
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$MASS stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in MASS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MASS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MASS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
MASS Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Revenue: | $16.07M | 33.02% |
| Handheld product and service revenue | $15.45M | 31.74% |
| Device sales revenue | $11.02M | 22.64% |
| Recurring revenue | $4.95M | 10.16% |
| OEM and funded partnership revenue | $612.00K | 1.26% |
| Global pharmaceutical, industrial and other | $463.00K | 0.95% |
| Contract revenue | $104.00K | 0.21% |
| Program product and service revenue | $10.00K | 0.02% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New MASS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MASS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in MASS
| ETF | Est. Holding Size |
|---|---|
| ARKGARK Genomic Revolution ETF | $23.47M |
| AVUVAvantis U.S. Small Cap Value ETF | $11.68M |
| IWMiShares Russell 2000 ETF | $10.05M |
| VTIVanguard Morningstar Total Stock Market ETF | $9.81M |
| VXFVanguard Extended Market ETF | $3.63M |
| IWNiShares Russell 2000 Value ETF | $3.44M |
Estimated from each fund’s disclosed top holdings × AUM
MASS Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from MASS’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score